The facultative anaerobic energy metabolism of Schistosoma mansoni sporocysts.
Schistosoma mansoni miracidia in water are known to possess an aerobic energy metabolism, the Krebs cycle being the main terminal of the breakdown of endogenous glycogen reserves. The present study demonstrated that after in vitro transformation of miracidia into sporocysts, the organisms degraded glucose to lactate and carbon dioxide in a more anaerobic ratio than do miracidia. The occurrence of a large Pasteur effect demonstrated, however, that oxidative phosphorylation was still the major process used for energy generation. After 24 h in vitro cultivation the sporocysts had consumed more external glucose and their metabolism had shifted towards lactate production. Sporocysts could cope with inhibited respiration: they had a large anaerobic capacity and survived perfectly in the presence of cyanide, producing a large amount of succinate in addition to lactate. It was demonstrated that this succinate was largely produced via phosphoenolpyruvate carboxykinase (PEPCK). This pathway, which is known to occur in most parasitic helminths, has never been demonstrated in schistosomes, not even in the miracidial stage immediately preceding the sporocysts. It was also shown that in sporocysts part of the lactate was not formed directly by glycolysis, but via a detour including fumarate and the action of PEPCK. The results demonstrated that S. mansoni sporocysts are facultative anaerobes, fully equipped to adjust their energy metabolism to the variable conditions inside their intermediate host, the snail. In the presence of oxygen, they derive most of their energy from the aerobic degradation of glucose to carbon dioxide, but under anaerobic conditions they switch towards lactate and succinate production.
Tielens
A G
AG
Laboratory of Veterinary Biochemistry, Utrecht University, The Netherlands.
Horemans
A M
AM
Dunnewijk
R
R
van der Meer
P
P
van den Bergh
S G
SG
D000693:Anaerobiosis / Q000187:drug effects; D000818:Animals; D003486:Cyanides / Q000494:pharmacology; D004734:Energy Metabolism / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000378:metabolism; D010848:Picolinic Acids / Q000494:pharmacology; D012550:Schistosoma mansoni / Q000254:growth & development / Q000378:metabolism*; D013386:Succinates / Q000378:metabolism; D019802:Succinic Acid
D003486:Cyanides; D010848:Picolinic Acids; D013386:Succinates; C008363:3-mercaptopicolinic acid; D019802:Succinic Acid; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D005947:Glucose